| Nov 12 |
Annovis Invited to Present at National Institute on Aging Workshop on Dementia with Lewy Bodies (DLB)
|
| Nov 11 |
Annovis Bio GAAP EPS of -$0.97 misses by $0.58
|
| Nov 11 |
Annovis Bio Reports Third Quarter Financial Results and Provides Business Update
|
| Nov 11 |
Will Annovis Bio (NYSE:ANVS) Spend Its Cash Wisely?
|
| Nov 7 |
Annovis Bio Appoints Matthew Peterson, Ph.D., as Senior Clinical Scientist
|
| Oct 31 |
IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Maria Maccecchini, CEO of Annovis Bio
|
| Oct 22 |
Annovis to Highlight Buntanetap's Alzheimer's Research Progress with Presentations at CTAD 2024
|
| Oct 17 |
Annovis Bio: Funding May Be An Issue For Announced Phase 3 Trials
|
| Oct 17 |
Annovis Bio To Continue Alzheimer's Disease Clinical Trials
|
| Oct 17 |
Annovis Bio Shows Promise on FDA Clearance for Alzheimer's Drug
|
